Author:
Tavares G.,Marques D.,Barra C.,Rosendo-Silva D.,Costa A.,Rodrigues T.,Gasparini P.,Melo B.F.,Sacramento J.F.,Seiça R.,Conde S.V.,Matafome P.
Funder
Fundação para a Ciência e a Tecnologia
Subject
Cell Biology,Molecular Biology
Reference38 articles.
1. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance;Goossens;Physiology & Behavior,2007
2. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes;Guilherme;Nature Reviews Molecular Cell Biology,2008
3. Mechanisms of obesity-associated insulin resistance: many choices on the menu;Qatanani;Genes & Development,2007
4. Impact of bromocriptine-QR therapy on glycemic control and daily insulin requirement in type 2 diabetes mellitus subjects whose dysglycemia is poorly controlled on high-dose insulin: a pilot study;Roe;International Journal of Diabetes Research,2015
5. Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes;Via;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy,2010
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献